Back to first-pass browser

First-pass extracted concept

genetic engineering

Candidate: concept label2 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The review identifies genetic engineering as a future-direction area intended to improve CAR-T efficacy and safety in glioblastoma.

Source 2DOIPubMed

Evidence Snippets

Key molecular strategies discussed include the use of genetic engineering to enhance the efficacy of biopesticides.
Evidence 1Source 1DOIPubMedprovenance
continued research and innovation in genetic engineering and combination therapies
Evidence 2Source 2DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1integration strategysupports2026Source 1DOIPubMed

Integrating molecular and microbial strategies is described as enabling development of effective biopesticides tailored to specific fungal threats.

Quoted textsource-backed
integrating molecular and microbial strategies can lead to the development of effective biopesticides tailored to combat specific fungal threats
Claim 2mechanism or strategysupports2026Source 1DOIPubMed

Genetic engineering is discussed as a molecular strategy to enhance biopesticide efficacy.

Quoted textsource-backed
the use of genetic engineering to enhance the efficacy of biopesticides
Claim 3future directionsupports2025Source 2DOIPubMed

Further innovation in genetic engineering and combination therapies is needed to fully realize the potential of CAR-T cells in glioblastoma.

Quoted textsource-backed
emphasizing the need for continued research and innovation in genetic engineering and combination therapies to fully realize the potential of CAR-T cells